Procurement Summary
Country: Kazakhstan
Summary: Purchasing Medical Devices for Laboratories, Amt: 1112068.00
Deadline: 17 Apr 2026
Posting Date: 18 Apr 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 139727521
Document Ref. No.: 16803602-1
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: KZT 1112068.00
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details
Tender Details
Lots: Set of reagents - Reagent for determining activated partial thrombin time (aPTT) in human citrated plasma. The APTT method is used as the main screening method for assessing disorders of the intrinsic coagulation pathway and for monitoring heparin anticoagulant therapy. The method is sensitive to reduced concentrations of contact phase factors, intrinsic and common coagulation pathway factors, the anticoagulative effect of heparin and the presence of inhibitors, in particular lupus-like anticoagulants. Recommended for use for preoperative screening diagnostics. Release form: liquid, ready for use. Determination methods: nephelometry or turbidimetry. (pack: 5 bottles of 10 ml of reagent + 5 bottles of 10 ml calcium chloride). Storage temperature +2 +8 C. Packing: 5 fl. 10 ml of reagent + 5 fl. 10 ml of calcium chloride. Determination methods: nephelometry or turbidimetry. Used to work on the “Closed” system of analyzers of the ACL TOP family (300, 500, 700) and ACL Elite PRO | Reagent for the determination of prothrombin time (PT), INR and estimated fibrinogen in human citrated plasma. Used to evaluate the extrinsic hemostatic pathway and monitor OAT. The reagent contains recombinant human tissue factor, characterized by MIC ~ 1. The reagent is stable on board the analyzer for 10 days. Release form: liquid (ready to use). Packing: 5 fl. 20 ml of reagent. Determination methods: nephelometry or turbidimetry. Use...
Documents
Tender Notice